Comparison Chart Alector, Inc.

Stocks

ALEC

US0144421072

Biotechnology & Medical Research

Market Closed - Nasdaq 23:00:00 08/10/2026 +03			After hours 23:26:42
2.020 ^USD	+5.21%		2.010	-0.50%

10-05	Alector Shares Rise After Licensing AL050 Program to Roche's Genentech	MT
10-05	Alector, Inc. And Genentech, Inc. Enter Global License Agreement For Brain Penetrant GCase Enzyme Replacement Therapy For Parkinsons Disease And Other Neurodegenerative Diseases	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ALECTOR, INC.	Bio Therapeutic Drugs	+5.21%	+8.60%	+29.49%	-34.42%	-91.37%	214M